These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6136893)

  • 1. Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus.
    Dimitriadis G; Tessari P; Gerich J
    Metabolism; 1983 Oct; 32(10):987-92. PubMed ID: 6136893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus.
    Dimitriadis GD; Tessari P; Go VL; Gerich JE
    Metabolism; 1985 Mar; 34(3):261-5. PubMed ID: 3883097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus.
    Spinas GA; Bock A; Keller U
    Diabetes Care; 1985; 8(5):429-35. PubMed ID: 2865093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, pharmacokinetics and tolerability of a somatostatin analogue (L-363,586) in insulin-dependent diabetes mellitus.
    Gottesman I; Tobert J; Vandlen R; Gerich J
    Life Sci; 1986 Jun; 38(24):2211-9. PubMed ID: 2872569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of twice daily subcutaneous administration of a long-acting somatostatin analog on 24-hour plasma glucose profiles in patients with insulin-dependent diabetes mellitus.
    Dimitriadis G; Gerich J
    Horm Metab Res; 1985 Oct; 17(10):510-1. PubMed ID: 2866155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus.
    Gerich JE; Lorenzi M; Karam JH; Schneider V; Forsham PH
    JAMA; 1975 Oct; 234(2):159-5. PubMed ID: 1242153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial glycaemic effects of a long-acting somatostatin analogue (octreotide) in non-insulin dependent diabetes mellitus.
    Williams G; Füessl HS; Burrin JM; Chilvers E; Bloom SR
    Horm Metab Res; 1988 Mar; 20(3):168-70. PubMed ID: 2898427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a new long-acting somatostatin analogue (SMS 201-995) on glycemic and hormonal response to a mixed meal in acromegalic patients.
    Candrina R; Gussago A; Giustina G
    J Endocrinol Invest; 1988 Jan; 11(1):21-6. PubMed ID: 2896207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary experience on treatment of insulin-dependent diabetes mellitus with a long-acting somatostatin analogue (L363,586).
    Bolli GB; Gottesman IS; Gerich JE
    Horm Res; 1988; 29(2-3):95-8. PubMed ID: 2900206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics.
    Neuhaus C; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):115-8. PubMed ID: 395066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus.
    Wahren J
    Lancet; 1976 Dec; 2(7997):1213-6. PubMed ID: 63040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin analog SMS 201-995 and insulin needs in insulin-dependent diabetic patients studied by means of an artificial pancreas.
    Rios MS; Navascues I; Saban J; Ordoñez A; Sevilla F; Del Pozo E
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1071-4. PubMed ID: 2876005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization.
    Gutniak M; Grill V; Wiechel KL; Efendić S
    Diabetes; 1987 Jul; 36(7):802-7. PubMed ID: 2884157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of the Dawn phenomenon (early morning hyperglycemia) in insulin-dependent diabetes mellitus by bedtime intranasal administration of a long-acting somatostatin analog.
    Campbell PJ; Bolli GB; Gerich JE
    Metabolism; 1988 Jan; 37(1):34-7. PubMed ID: 2892113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue.
    Kolterman OG; Gottlieb A; Moyses C; Colburn W
    Diabetes Care; 1995 Aug; 18(8):1179-82. PubMed ID: 7587855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.
    Levetan C; Want LL; Weyer C; Strobel SA; Crean J; Wang Y; Maggs DG; Kolterman OG; Chandran M; Mudaliar SR; Henry RR
    Diabetes Care; 2003 Jan; 26(1):1-8. PubMed ID: 12502651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of the somatostatin analogue SMS 201-995 on carbohydrate homeostasis of insulin-dependent diabetics as assessed by the artificial endocrine pancreas.
    Hadjidakis DJ; Halvatsiotis PG; Ioannou YJ; Mavrokefalos PJ; Raptis SA
    Diabetes Res Clin Pract; 1988 Jul; 5(2):91-8. PubMed ID: 2901329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a zinc phosphate suspension of a long-acting somatostatin analog on postprandial plasma glucose, triglyceride and glucagon concentrations in alloxan diabetic dogs.
    Martin C; Wallum B; Krom B; Hall L; Gerich J
    Life Sci; 1984 Dec; 35(26):2627-33. PubMed ID: 6151111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a long-acting somatostatin derivative SMS 201-995 (sandostatin) on glucose homeostasis in type I diabetes mellitus.
    Navascues I; Gil J; Pascau C; Senén D; del Pozo E; Serrano-Ríos M
    Horm Res; 1988; 29(2-3):92-4. PubMed ID: 2900205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin reduces posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus.
    Kollind M; Adamson U; Lins PE
    Acta Endocrinol (Copenh); 1988 Jun; 118(2):173-8. PubMed ID: 2898855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.